[HTML][HTML] Optimizing antibiotic therapies to reduce the risk of bacterial resistance

S Bassetti, S Tschudin-Sutter, A Egli… - European journal of …, 2022 - Elsevier
The incidence of infections caused by bacteria that are resistant to antibiotics is constantly
increasing. In Europe alone, it has been estimated that each year about 33′ 000 deaths are …

The impact of coronavirus disease 2019 on viral, bacterial, and fungal respiratory infections

A Losier, G Gupta, M Caldararo… - Clinics in chest …, 2023 - chestmed.theclinics.com
Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic in Wuhan,
China, in December 2019, there has been a significant focus placed on its transmission …

Respiratory viruses: their importance and lessons learned from COVID-19

C Cilloniz, CM Luna, JC Hurtado… - European …, 2022 - Eur Respiratory Soc
Respiratory virus infection can cause severe illnesses capable of inducing acute respiratory
failure that can progress rapidly to acute respiratory distress syndrome (ARDS). ARDS is …

Antimicrobial stewardship using biomarkers: Accumulating evidence for the critically ill

E Kyriazopoulou, EJ Giamarellos-Bourboulis - Antibiotics, 2022 - mdpi.com
This review aims to summarize current progress in the management of critically ill, using
biomarkers as guidance for antimicrobial treatment with a focus on antimicrobial …

Bacterial ventilator-associated pneumonia in COVID-19 patients: data from the second and third waves of the pandemic

A Russo, V Olivadese, EM Trecarichi… - Journal of Clinical …, 2022 - mdpi.com
During the coronavirus disease 2019 (COVID-19) pandemic, many patients requiring
invasive mechanical ventilation were admitted to intensive care units (ICU) for COVID-19 …

Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review

S Boyd, S Nseir, A Rodriguez… - ERJ open …, 2022 - Eur Respiratory Soc
COVID pneumonitis can cause patients to become critically ill. They may require intensive
care and mechanical ventilation. Ventilator-associated pneumonia (VAP) is a concern. This …

Ceftazidime/avibactam in ventilator-associated pneumonia due to difficult-to-treat non-fermenter Gram-negative bacteria in COVID-19 patients: a case series and …

GJ Burastero, G Orlando, A Santoro, M Menozzi… - Antibiotics, 2022 - mdpi.com
Ventilator-associated pneumonia (VAP) in critically ill patients with COVID-19 represents a
very huge global threat due to a higher incidence rate compared to non-COVID-19 patients …

[HTML][HTML] Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in …

HY Wu, PH Chang, YS Huang, CS Tsai… - Journal of Microbiology …, 2023 - Elsevier
Abstract Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by
SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections …

Systemic inflammatory predictors of in-hospital mortality in COVID-19 patients: a retrospective study

B Kudlinski, D Zgoła, M Stolińska, M Murkos, J Kania… - Diagnostics, 2022 - mdpi.com
The purpose of this study was to investigate whether routine blood tests and clinical
characteristics can predict in-hospital mortality in COVID-19. Clinical data of 285 patients …

Procalcitonin and NEWS2 evaluation for timely identification of sepsis and optimal use of antibiotics in the emergency department (PRONTO): protocol for a …

J Euden, E Thomas-Jones, S Aston… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Sepsis is a common, potentially life-threatening complication of infection. The
optimal treatment for sepsis includes prompt antibiotics and intravenous fluids, facilitated by …